Replies to post #149642 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

This is what has me worried.

Could it possibly be that we still have not hit the target 233 OS events to end the trial? My gut says no way it lasted beyond August, but it would only take about 35-40% of treatment arm patients and 15-20% of crossovers to have moderately long tail survival to make our wait an enormous one.

Could it e 99 patients are still living and data lock has not yet begun? Maybe

I am so frustrated by the lack of communication with shareholders it's not even fun to dream anymore. I am with you that there is no end in sight now. GIVE ME AN UPDATE DAMMIT!